(Q30665022)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24005770%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

Bevacizumab for radiation necrosis following treatment of high grade glioma: a systematic review of the literature (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24005770%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24005770%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Kalil G Abdullah

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24005770%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Robert J Weil

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24005770%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Nicholas F Marko

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24005770%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

publication date

5 September 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24005770%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

19 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24005770%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24005770%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24005770%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

317-322

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24005770%20AND%20SRC:MED&resulttype=core&format=json

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

19 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Radiation necrosis following treatment of high grade glioma--a review of the literature and current understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Pseudoprogression: relevance with respect to treatment of high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Medical management of brain tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

The treatment of radiation necrosis with hyperbaric oxygen (OHP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Hyperbaric oxygen therapy for radiation-induced brain injury in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Successful treatment of radiation-induced brain necrosis by hyperbaric oxygen therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

The efficacy of hyperbaric oxygen therapy in the treatment of radiation-induced late side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Effect of bevacizumab on radiation necrosis of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Bevacizumab as a treatment option for radiation-induced cerebral necrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Use of Bevacizumab for neurological complications during initial treatment of malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

The paradoxical effect of bevacizumab in the therapy of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Unexpected late radiation neurotoxicity following bevacizumab use: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Optic neuropathy in patients with glioblastoma receiving bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Should the cost of care for patients with glioblastoma influence treatment decisions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1233-0

Treatment of radiation-induced nervous system injury with heparin and warfarin

21 January 2018

1 reference

12 December 2020

Phase II study of bevacizumab in combination with sorafenib in recurrent glioblastoma (N0776): a north central cancer treatment group trial

1 reference

12 December 2020

[Bevacizumab for the treatment of cerebral radionecrosis]

1 reference

12 December 2020

Cerebral radiation necrosis

1 reference

12 December 2020